ABBV had a solid reaction to earnings. The tight consolidation over the last few days supports a bullish momentum holding up. Volume declining over the last few days (when price has been declining) typically means a healthy consolidation before a continued rise.
While the price may/may not continue down a bit more, if it starts to climb back up, the 201 area would be a place I'd consider an entry (either call option or stock). I'd place a stop around 194, and a first profit target when the price extends again from its 10EMA.
That area of 201 for entry will be where the price rises above the moving averages on the 15m and 1h chart time frames, and the 10EMA crossing back above the 20EMA on the 15m timeframe.
1h
While the price may/may not continue down a bit more, if it starts to climb back up, the 201 area would be a place I'd consider an entry (either call option or stock). I'd place a stop around 194, and a first profit target when the price extends again from its 10EMA.
That area of 201 for entry will be where the price rises above the moving averages on the 15m and 1h chart time frames, and the 10EMA crossing back above the 20EMA on the 15m timeframe.
1h
交易結束：達到停損點
Wow. Great lesson here. First time I experiencing such a drop from a drug trial fail. Some major wins for me here: experience, having reduced how much I put in my trades lately + diversifying. 
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。